Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
November 2015—Mindray received 510(k) clearance to market and sell the Mindray BC-3600 Auto Hematology Analyzer, which aims to meet the testing needs of small and mid-volume hematology laboratories. The BC-3600 Hematology Analyzer features closed-tube sampling via a single push button.
November 2015—Thermo Fisher Scientific received the in vitro diagnostics device CE mark for its Thermo Scientific Prelude MD HPLC, Endura MD mass spectrometer, and ClinQuan MD software.
November 2015—Clarient Diagnostics will offer the FDA-approved PD-L1 companion diagnostic, which will help identify patients most likely to benefit from Merck’s lung cancer drug Keytruda.
November 2015—Streck has acquired Fertility Solutions’ sperm count and post-vasectomy quality control products. The sperm count controls for fertility diagnosis have been renamed Sperm-Chex and Sperm-Chex Post VC.
Roche has signed a definitive agreement to acquire Kapa Biosystems, a privately held company that employs proprietary technologies to optimize enzymes for next-generation sequencing as well as polymerase chain reaction and real-time PCR applications.
Lab Sensor Solutions will partner with MarketLab to distribute T-Tracks, which tracks, in real time, the temperature and location of clinical samples in transit, preventing laboratory specimen spoilage and loss and ensuring regulatory compliance. T-Tracks data are delivered to lab personnel’s desktops, laptops, and mobile devices.
QuanDx announced that its Leukemia Fusion Genes (Q30) Screening Kit has been released as a CE IVD product. The Leukemia Fusion Genes (Q30) product is a qualitative in vitro diagnostic kit for use in a clinical laboratory for the simultaneous detection of 30 fusion genes using a novel multiplex reverse transcription real-time PCR system.
Early results from a randomized trial for lung cancer using autoantibody biomarkers were announced at the International Association for the Study of Lung Cancer’s 16th World Conference on Lung Cancer, held Sept. 6–9 in Denver.
Biocartis launched its CE-IVD Idylla KRAS Mutation Test, a sample-to-result test for the fast, accurate, and reproducible detection of 21 relevant mutations in the KRAS oncogene. The fully automated test, for routine use, detects all clinically relevant driver mutations of the KRAS oncogene in tissue of colorectal cancers at a sensitivity of five percent.
The results of a large, multicenter prospective clinical study that validates the ability of MeMed’s ImmunoXpert in vitro diagnostic blood test to determine whether a patient has an acute bacterial or viral infection was published in the March 18, 2015 online edition of Plos One.
